Cargando…

Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives

Pulmonary arterial hypertension (PAH) is a severe and progressive disease, characterised by high pulmonary artery pressure that usually culminates in right heart failure. Recent findings of alterations in the DNA methylation state of superoxide dismutase 2 and granulysin gene loci; histone H1 levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chelladurai, Prakash, Seeger, Werner, Pullamsetti, Soni Savai
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2016
Materias:	Lung Science Conference
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487251/ https://www.ncbi.nlm.nih.gov/pubmed/27246590 http://dx.doi.org/10.1183/16000617.0036-2016

Ejemplares similares

Mechanics and mechanisms of pulmonary hypertension—Conference summary and translational perspectives
por: Seeger, Werner, et al.
Publicado: (2013)

Metabolism in tumour-associated macrophages: a quid pro quo with the tumour microenvironment
por: Zheng, Xiang, et al.
Publicado: (2020)

Cancer and pulmonary hypertension: Learning lessons and real-life interplay
por: Pullamsetti, Soni Savai, et al.
Publicado: (2020)

Zooming into Cellular and Molecular Heterogeneity of Pulmonary Hypertension. What More Single-Cell Omics Can Offer
por: Chelladurai, Prakash, et al.
Publicado: (2021)

Exposomes to Exosomes: Exosomes as Tools to Study Epigenetic Adaptive Mechanisms in High-Altitude Humans
por: Padmasekar, Manju, et al.
Publicado: (2021)

Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets?
por: Avci, Edibe, et al.
Publicado: (2022)

EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition
por: Pullamsetti, Soni Savai, et al.
Publicado: (2019)

Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension
por: Sklepkiewicz, Piotr, et al.
Publicado: (2011)

Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension
por: Chelladurai, Prakash, et al.
Publicado: (2020)

Epigenetic silencing of downstream genes mediated by tandem orientation in lung cancer
por: Kiehl, Steffen, et al.
Publicado: (2017)

Matrix abnormalities in pulmonary fibrosis
por: Upagupta, Chandak, et al.
Publicado: (2018)

Immune checkpoints in chronic obstructive pulmonary disease
por: Wilkinson, Tom M.A.
Publicado: (2017)

Pharmacology and Rationale for Seralutinib in the Treatment of Pulmonary Arterial Hypertension
por: Pullamsetti, Soni Savai, et al.
Publicado: (2023)

The multifaceted roles of the matrikine Pro-Gly-Pro in pulmonary health and disease
por: Patel, Dhiren F., et al.
Publicado: (2018)

The contribution of infection and the respiratory microbiome in acute exacerbations of idiopathic pulmonary fibrosis
por: Invernizzi, Rachele, et al.
Publicado: (2019)

Hypoxic pulmonary hypertension in mice with constitutively active platelet-derived growth factor receptor-β
por: Dahal, Bhola K., et al.
Publicado: (2011)

Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension
por: Weiss, Astrid, et al.
Publicado: (2019)

Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression
por: Karger, Annika, et al.
Publicado: (2021)

A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension
por: Dabral, Swati, et al.
Publicado: (2019)

Intersections of lung progenitor cells, lung disease and lung cancer
por: Kim, Carla F.
Publicado: (2017)

Cell therapy for lung disease
por: Geiger, Sabine, et al.
Publicado: (2017)

Shared epithelial pathways to lung repair and disease
por: Spella, Magda, et al.
Publicado: (2017)

Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
por: Lai, Rocky, et al.
Publicado: (2015)

Acellular human lung scaffolds to model lung disease and tissue regeneration
por: Gilpin, Sarah E., et al.
Publicado: (2018)

Therapeutic strategies in pneumonia: going beyond antibiotics
por: Müller-Redetzky, Holger, et al.
Publicado: (2015)

Macrophage adaptation in airway inflammatory resolution
por: Kaur, Manminder, et al.
Publicado: (2015)

The heterogeneity of lung macrophages in the susceptibility to disease
por: Morales-Nebreda, Luisa, et al.
Publicado: (2015)

The exposome concept: a challenge and a potential driver for environmental health research
por: Siroux, Valérie, et al.
Publicado: (2016)

Natural experiments and large databases in respiratory and cardiovascular disease
por: Vestbo, Jørgen
Publicado: (2016)

Influence of the lung microbiome on antibiotic susceptibility of cystic fibrosis pathogens
por: Vandeplassche, Eva, et al.
Publicado: (2019)

How bacteria hack the matrix and dodge the bullets of immunity
por: Paulsson, Magnus, et al.
Publicado: (2018)

The ageing lung under stress
por: Korfei, Martina, et al.
Publicado: (2020)

Endoplasmic reticulum stress in lung disease
por: Marciniak, Stefan J.
Publicado: (2017)

Mitochondrial dysfunction in lung ageing and disease
por: Cloonan, Suzanne M., et al.
Publicado: (2020)

Therapeutic targeting of metabolic alterations in acute respiratory distress syndrome
por: Robinson, Matthew John, et al.
Publicado: (2020)

Respiratory muscle senescence in ageing and chronic lung diseases
por: Gea, Joaquim, et al.
Publicado: (2020)

The consequence of matrix dysfunction on lung immunity and the microbiome in COPD
por: Hussell, Tracy, et al.
Publicado: (2018)

Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling
por: Tian, Xia, et al.
Publicado: (2011)

A FOX-like Mechanism Regulating Lung Fibroblasts: Are We Getting There?
por: Pullamsetti, Soni Savai, et al.
Publicado: (2020)

Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension
por: Hautefort, Aurélie, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_4ch0viq1t18gklfm5991colmmu